A phase II clinical trial of vaccination of stem cell donors with Zostavax to reduce the incidence of herpes zoster in transplant recipients - a pilot study.
Phase of Trial: Phase II
Latest Information Update: 09 May 2017
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster
- Focus Therapeutic Use
- Acronyms VAZDOVA
- Sponsors Merck Sharp & Dohme
- 02 May 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
- 02 May 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 14 Dec 2014 Planned number of patients changed from 40 to 10 according to ClinicalTrials.gov record.